Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy

被引：42

作者：

Fisk, TL ^{[1
]}

Hon, HM

Lennox, JL

von Reyn, CF

Horsburgh, CR

机构：

[1] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA

[2] Grady Mem Hosp, Atlanta, GA USA

[3] Emory Univ, Sch Med, Atlanta, GA USA

[4] Dartmouth Hitchcock Med Ctr, Infect Dis Sect, Lebanon, NH 03766 USA

[5] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

来源：

AIDS | 2003年 / 17卷 / 07期

关键词：

D O I：

10.1097/00002030-200305020-00027

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This cross-sectional study of 110 individuals examined skin testing for latent tuberculosis infection (LTBI) after the initiation of highly active antiretroviral therapy. Skin test reactivity to one or more of four antigens was found in 98 out of 110 subjects (89%), and was maximal in those whose CD4 cell counts recovered to greater than or equal to100 cells/mm(3). Skin testing is reliable for the identification or exclusion of LTBI once the CD4 cell count recovers to greater than or equal to100 cells/mm(3).

引用

页码：1102 / 1104

页数：3

共 50 条

[31] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
Moore, RD
Forney, D
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 54 - 57
[32] Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy
Puthanakit, Thanyawee
Aurpibul, Linda
Oberdorfer, Peninnah
Akarathum, Noppadon
Kanjananit, Suparat
Wannarit, Pornphun
Sirisanthana, Thira
Sirisanthana, Virat
CLINICAL INFECTIOUS DISEASES, 2007, 44 (04) : 599 - 604
[33] A Study of Cytomegalovirus Serology among HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era
Sufiawati, Irna
Widyaputra, Sunardhi
Djajakusumah, Tony S.
MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2013, 45 (02): : 112 - 117
[34] Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Girardi, E
Antonucci, G
Vanacore, P
Palmieri, F
Matteelli, A
Iemoli, E
Carradori, S
Salassa, B
Pasticci, MB
Raviglione, MC
Ippolito, G
EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (01) : 11 - 17
[35] Lymphoma developing shortly after the onset of highly active antiretroviral therapy in HIV-infected patients
Collazos, J
Ojanguren, J
Mayo, J
Martínez, E
Ibarra, S
AIDS, 2002, 16 (09) : 1304 - 1306
[36] Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy
Arildsen, H.
Sorensen, K. E.
Ingerslev, J. M.
Ostergaard, L. J.
Laursen, A. L.
HIV MEDICINE, 2013, 14 (01) : 1 - 9
[37] Graves' Disease as a Manifestation of Immune Reconstitution in HIV-Infected Individuals after Initiation of Highly Active Antiretroviral Therapy
Rasul, Samad
Delapenha, Robert
Farhat, Faria
Gajjala, Jhansi
Zahra, Syeda Mehreen
AIDS RESEARCH AND TREATMENT, 2011, 2011
[38] Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study
Stockdale, Alexander J.
Nkuranga, Joseph
Toeroek, M. Estee
Faragher, Brian
Lalloo, David G.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 (07) : 907 - 914
[39] Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy
Cheng, Chien-Yu
Chen, Mao-Yuan
Hsieh, Szu-Min
Sheng, Wang-Huei
Sun, Hsin-Yun
Lo, Yi-Chun
Liu, Wen-Chun
Hung, Chien-Ching
BMC INFECTIOUS DISEASES, 2010, 10
[40] Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy
Chien-Yu Cheng
Mao-Yuan Chen
Szu-Min Hsieh
Wang-Huei Sheng
Hsin-Yun Sun
Yi-Chun Lo
Wen-Chun Liu
Chien-Ching Hung
BMC Infectious Diseases, 10

← 1 2 3 4 5 →